We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
Cap. Flow
-$587M
Cap. Flow %
-4.35%
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38

Top Buys

Rank Stock Value
1
MPLX icon
MPLX
MPLX
+$30.1M
2
ET icon
Energy Transfer Partners
ET
+$24.7M
3
FLJP icon
Franklin FTSE Japan ETF
FLJP
+$11.8M
4
WFC icon
Wells Fargo
WFC
+$9.66M
5
ALKS icon
Alkermes
ALKS
+$8.97M

Sector Composition

Rank Sector Weight
1 Energy 65.41%
2 Financials 7.05%
3 Healthcare 3.6%
4 Consumer Discretionary 3.1%
5 Technology 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSM icon
201
Fortuna Silver Mines
FSM
$2.59B
$2.65M 0.02%
929,365
+204,187
+28% +$590K
INTU icon
202
Intuit
INTU
$81.1B
$2.6M 0.02%
9,963
-372
-4% -$94.5K
VGIT icon
203
Vanguard Intermediate-Term Treasury ETF
VGIT
$41.6B
$2.55M 0.02%
38,601
-87,812
-69% -$5.69M
ARQL
204
DELISTED
Arqule Inc
ARQL
$2.52M 0.02%
228,788
-34,474
-13% -$240K
ROP icon
205
Roper Technologies
ROP
$36.3B
$2.51M 0.02%
6,852
-708
-9% -$251K
AMGN icon
206
Amgen
AMGN
$203B
$2.49M 0.02%
13,517
-206
-2% -$36.9K
MIC
207
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$2.46M 0.02%
60,680
-8,606
-12% -$353K
AM icon
208
Antero Midstream
AM
$10.8B
$2.44M 0.02%
212,906
+3,304
+2% +$42.3K
AUY
209
DELISTED
Yamana Gold, Inc.
AUY
$2.44M 0.02%
966,989
-119,703
-11% -$263K
GTHX
210
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2.4M 0.02%
78,412
-11,404
-13% -$240K
EIDX
211
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$2.4M 0.02%
+77,075
New +$2.09M
EPZM
212
DELISTED
Epizyme, Inc
EPZM
$2.39M 0.02%
+190,125
New +$2.45M
MU icon
213
Micron Technology
MU
$1.04T
$2.37M 0.02%
61,343
+4,342
+8% +$165K
DRNA
214
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.25M 0.02%
+143,000
New +$1.94M
DPZ icon
215
Domino's
DPZ
$11B
$2.23M 0.02%
7,997
-904
-10% -$247K
NDSN icon
216
Nordson
NDSN
$16.5B
$2.22M 0.02%
15,715
-237
-1% -$32.6K
AMT icon
217
American Tower
AMT
$77.7B
$2.18M 0.02%
10,664
-2,051
-16% -$412K
PLD icon
218
Prologis
PLD
$138B
$2.15M 0.02%
26,826
-4,338
-14% -$330K
VYGR icon
219
Voyager Therapeutics
VYGR
$187M
$2.1M 0.02%
77,092
-1,545
-2% -$35.4K
UNH icon
220
UnitedHealth
UNH
$382B
$2.09M 0.02%
8,551
-1,572
-16% -$378K
GE icon
221
GE Aerospace
GE
$367B
$2.08M 0.02%
39,819
-3,346
-8% -$165K
ANF icon
222
Abercrombie & Fitch
ANF
$4.17B
$2.08M 0.02%
129,455
+16,288
+14% +$377K
BAX icon
223
Baxter International
BAX
$11.6B
$2.02M 0.01%
24,601
-3,011
-11% -$234K
CWEN icon
224
Clearway Energy Class C
CWEN
$5B
$2M 0.01%
118,911
+59,377
+100% +$937K
DLR icon
225
Digital Realty Trust
DLR
$73.7B
$1.96M 0.01%
16,638
+344
+2% +$41K

Similar funds

ALPS Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.

Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.

  • ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
  • ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
  • ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
  • ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
  • ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
  • ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
  • ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.

Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.